Kidney Cancer Journal is the official Journal of the Kidney Cancer Association. The objective of KCJ is to serve as the most comprehensive, peer-reviewed resource of information for physicians on the diagnosis and treatment of renal cell carcinoma and its tumor types. KCJ supports the mission of the Kidney Caner Association by facilitating the knowledge transfer, contributing to cancer prevention, early detection, diagnosis, and cure of kidney cancer. KCJ publishes original articles, reviews, clinical case studies as well as letters to the editor.
Kidney Cancer Journal is the only peer-reviewed medical journal and most comprehensive source of scientific information focusing exclusively on renal cell carcinoma. In addition, special reports and supplements covering ASCO meeting and highlights from the annual International Kidney Cancer Association Meeting also published. KCJ is distributed as a complimentary professional service to approximately 12,300 physicians, including all medical oncologists and targeted urologists. KCJ utilizes a Medical Advisory Board and Editorial Advisory Board of more than 30 oncologists/physicians who are leading investigators in this field. Archives available through the KCA’s website at www.kidneycancer.org